25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Amphastar P
Buy, Hold or Sell?

Let's analyze Amphastar together

I guess you are interested in Amphastar P. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Amphastar P. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Amphastar P

I send you an email if I find something interesting about Amphastar P.

1. Quick Overview

1.1. Quick analysis of Amphastar (30 sec.)










1.2. What can you expect buying and holding a share of Amphastar? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
27.5%

What is your share worth?

Current worth
$14.03
Expected worth in 1 year
$17.02
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
$2.99
Return On Investment
6.5%

For what price can you sell your share?

Current Price per Share
$45.88
Expected price per share
$38.42 - $53.96
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Amphastar (5 min.)




Live pricePrice per Share (EOD)
$45.88
Intrinsic Value Per Share
$16.55 - $77.13
Total Value Per Share
$30.58 - $91.16

2.2. Growth of Amphastar (5 min.)




Is Amphastar growing?

Current yearPrevious yearGrowGrow %
How rich?$727.6m$565.4m$122.7m17.8%

How much money is Amphastar making?

Current yearPrevious yearGrowGrow %
Making money$39.4m$33.8m$5.6m14.2%
Net Profit Margin21.9%22.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Amphastar (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Amphastar?

Welcome investor! Amphastar's management wants to use your money to grow the business. In return you get a share of Amphastar.

First you should know what it really means to hold a share of Amphastar. And how you can make/lose money.

Speculation

The Price per Share of Amphastar is $45.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amphastar.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amphastar, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $14.03. Based on the TTM, the Book Value Change Per Share is $0.75 per quarter. Based on the YOY, the Book Value Change Per Share is $0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amphastar.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.781.7%0.751.6%0.641.4%0.400.9%0.220.5%
Usd Book Value Change Per Share0.320.7%0.751.6%0.370.8%0.270.6%0.200.4%
Usd Dividend Per Share0.000.0%0.000.0%0.090.2%0.040.1%0.070.1%
Usd Total Gains Per Share0.320.7%0.751.6%0.451.0%0.310.7%0.270.6%
Usd Price Per Share48.53-48.57-42.25-31.91-24.45-
Price to Earnings Ratio15.56-16.36-17.66--63.02-19.52-
Price-to-Total Gains Ratio149.33-79.87--534.44--70.52--144.20-
Price to Book Ratio3.46-3.74-3.91-3.03-2.76-
Price-to-Total Gains Ratio149.33-79.87--534.44--70.52--144.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share45.88
Number of shares21
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share0.750.27
Usd Total Gains Per Share0.750.31
Gains per Quarter (21 shares)15.726.44
Gains per Year (21 shares)62.8725.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10635332316
2012611664542
30189179106868
40251242139094
5031430516113120
6037736819135146
7044043122158172
8050349426180198
9056655729203224
10062962032226250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%17.03.00.085.0%30.010.00.075.0%37.014.00.072.5%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%26.014.00.065.0%29.016.06.056.9%
Dividend per Share0.00.04.00.0%5.00.07.041.7%6.00.014.030.0%11.00.029.027.5%11.00.040.021.6%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%28.012.00.070.0%31.014.06.060.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Amphastar P compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3250.748-57%0.367-11%0.269+21%0.204+60%
Book Value Per Share--14.03113.120+7%10.728+31%10.243+37%8.524+65%
Current Ratio--3.4332.826+21%2.871+20%2.920+18%2.815+22%
Debt To Asset Ratio--0.5290.550-4%0.441+20%0.377+40%0.322+64%
Debt To Equity Ratio--1.1231.230-9%0.937+20%0.705+59%0.540+108%
Dividend Per Share----0%0.088-100%0.038-100%0.066-100%
Eps--0.7800.751+4%0.644+21%0.396+97%0.221+253%
Free Cash Flow Per Share--0.8900.813+10%0.659+35%0.441+102%0.228+291%
Free Cash Flow To Equity Per Share--0.4500.365+23%2.933-85%0.746-40%0.393+15%
Gross Profit Margin--0.7780.771+1%0.795-2%1.940-60%1.013-23%
Intrinsic Value_10Y_max--77.126--------
Intrinsic Value_10Y_min--16.550--------
Intrinsic Value_1Y_max--3.300--------
Intrinsic Value_1Y_min--1.044--------
Intrinsic Value_3Y_max--13.290--------
Intrinsic Value_3Y_min--3.687--------
Intrinsic Value_5Y_max--27.350--------
Intrinsic Value_5Y_min--6.914--------
Market Cap2205974632.000-14%2516862860.0002551354897.500-1%2232389012.500+13%1649186714.700+53%1237209027.100+103%
Net Profit Margin--0.2140.219-2%0.222-4%0.140+53%0.086+150%
Operating Margin---0.221-100%0.274-100%0.183-100%0.070-100%
Operating Ratio--0.6980.703-1%0.706-1%0.816-14%0.915-24%
Pb Ratio3.270-6%3.4593.742-8%3.910-12%3.032+14%2.761+25%
Pe Ratio14.714-6%15.56316.355-5%17.663-12%-63.021+505%19.525-20%
Price Per Share45.880-6%48.53048.5730%42.245+15%31.915+52%24.447+99%
Price To Free Cash Flow Ratio12.884-6%13.62922.809-40%21.120-35%2.712+402%-128.442+1042%
Price To Total Gains Ratio141.180-6%149.33479.868+87%-534.436+458%-70.523+147%-144.201+197%
Quick Ratio--2.8212.455+15%2.206+28%2.125+33%1.809+56%
Return On Assets--0.0260.026+2%0.033-20%0.020+28%0.013+109%
Return On Equity--0.0560.057-3%0.060-7%0.037+52%0.022+156%
Total Gains Per Share--0.3250.748-57%0.455-29%0.307+6%0.270+20%
Usd Book Value--727678000.000688200250.000+6%565402500.000+29%524265600.000+39%427477400.000+70%
Usd Book Value Change Per Share--0.3250.748-57%0.367-11%0.269+21%0.204+60%
Usd Book Value Per Share--14.03113.120+7%10.728+31%10.243+37%8.524+65%
Usd Dividend Per Share----0%0.088-100%0.038-100%0.066-100%
Usd Eps--0.7800.751+4%0.644+21%0.396+97%0.221+253%
Usd Free Cash Flow--46169000.00042538500.000+9%34957750.000+32%22870350.000+102%11779350.000+292%
Usd Free Cash Flow Per Share--0.8900.813+10%0.659+35%0.441+102%0.228+291%
Usd Free Cash Flow To Equity Per Share--0.4500.365+23%2.933-85%0.746-40%0.393+15%
Usd Market Cap2205974632.000-14%2516862860.0002551354897.500-1%2232389012.500+13%1649186714.700+53%1237209027.100+103%
Usd Price Per Share45.880-6%48.53048.5730%42.245+15%31.915+52%24.447+99%
Usd Profit--40429000.00039430500.000+3%33822750.000+20%20648950.000+96%11672400.000+246%
Usd Revenue--188819000.000180288500.000+5%150328250.000+26%127871400.000+48%97345100.000+94%
Usd Total Gains Per Share--0.3250.748-57%0.455-29%0.307+6%0.270+20%
 EOD+4 -4MRQTTM+24 -10YOY+20 -165Y+24 -1210Y+27 -9

3.3 Fundamental Score

Let's check the fundamental score of Amphastar P based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.714
Price to Book Ratio (EOD)Between0-13.270
Net Profit Margin (MRQ)Greater than00.214
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.821
Current Ratio (MRQ)Greater than13.433
Debt to Asset Ratio (MRQ)Less than10.529
Debt to Equity Ratio (MRQ)Less than11.123
Return on Equity (MRQ)Greater than0.150.056
Return on Assets (MRQ)Greater than0.050.026
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Amphastar P based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.132
Ma 20Greater thanMa 5046.380
Ma 50Greater thanMa 10047.829
Ma 100Greater thanMa 20046.097
OpenGreater thanClose44.930
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Amphastar P

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Fundamental data was last updated by Penke on 2024-11-14 10:00:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Amphastar earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 21.4% means that $0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amphastar P:

  • The MRQ is 21.4%. The company is making a huge profit. +2
  • The TTM is 21.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ21.4%TTM21.9%-0.5%
TTM21.9%YOY22.2%-0.3%
TTM21.9%5Y14.0%+7.9%
5Y14.0%10Y8.6%+5.4%
4.3.1.2. Return on Assets

Shows how efficient Amphastar is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Assets means that Amphastar generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amphastar P:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.6%+0.0%
TTM2.6%YOY3.3%-0.7%
TTM2.6%5Y2.0%+0.5%
5Y2.0%10Y1.3%+0.8%
4.3.1.3. Return on Equity

Shows how efficient Amphastar is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.6% Return on Equity means Amphastar generated $0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amphastar P:

  • The MRQ is 5.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.6%TTM5.7%-0.2%
TTM5.7%YOY6.0%-0.2%
TTM5.7%5Y3.7%+2.1%
5Y3.7%10Y2.2%+1.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Amphastar P.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Amphastar is operating .

  • Measures how much profit Amphastar makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amphastar P:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM22.1%-22.1%
TTM22.1%YOY27.4%-5.3%
TTM22.1%5Y18.3%+3.8%
5Y18.3%10Y7.0%+11.3%
4.3.2.2. Operating Ratio

Measures how efficient Amphastar is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.70 means that the operating costs are $0.70 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Amphastar P:

  • The MRQ is 0.698. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.703. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.698TTM0.703-0.005
TTM0.703YOY0.706-0.003
TTM0.7035Y0.816-0.113
5Y0.81610Y0.915-0.099
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Amphastar P.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Amphastar is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.43 means the company has $3.43 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Amphastar P:

  • The MRQ is 3.433. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.826. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.433TTM2.826+0.607
TTM2.826YOY2.871-0.045
TTM2.8265Y2.920-0.094
5Y2.92010Y2.815+0.105
4.4.3.2. Quick Ratio

Measures if Amphastar is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.82 means the company can pay off $2.82 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amphastar P:

  • The MRQ is 2.821. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.455. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.821TTM2.455+0.366
TTM2.455YOY2.206+0.249
TTM2.4555Y2.125+0.330
5Y2.12510Y1.809+0.316
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Amphastar P.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Amphastar assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Amphastar to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that Amphastar assets are financed with 52.9% credit (debt) and the remaining percentage (100% - 52.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Amphastar P:

  • The MRQ is 0.529. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.550. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.529TTM0.550-0.021
TTM0.550YOY0.441+0.109
TTM0.5505Y0.377+0.173
5Y0.37710Y0.322+0.055
4.5.4.2. Debt to Equity Ratio

Measures if Amphastar is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 112.3% means that company has $1.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amphastar P:

  • The MRQ is 1.123. The company is able to pay all its debts with equity. +1
  • The TTM is 1.230. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.123TTM1.230-0.107
TTM1.230YOY0.937+0.293
TTM1.2305Y0.705+0.526
5Y0.70510Y0.540+0.165
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Amphastar generates.

  • Above 15 is considered overpriced but always compare Amphastar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 15.56 means the investor is paying $15.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amphastar P:

  • The EOD is 14.714. Based on the earnings, the company is underpriced. +1
  • The MRQ is 15.563. Based on the earnings, the company is fair priced.
  • The TTM is 16.355. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.714MRQ15.563-0.850
MRQ15.563TTM16.355-0.792
TTM16.355YOY17.663-1.307
TTM16.3555Y-63.021+79.376
5Y-63.02110Y19.525-82.546
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amphastar P:

  • The EOD is 12.884. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.629. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 22.809. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.884MRQ13.629-0.744
MRQ13.629TTM22.809-9.180
TTM22.809YOY21.120+1.689
TTM22.8095Y2.712+20.097
5Y2.71210Y-128.442+131.154
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Amphastar is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Amphastar P:

  • The EOD is 3.270. Based on the equity, the company is fair priced.
  • The MRQ is 3.459. Based on the equity, the company is fair priced.
  • The TTM is 3.742. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.270MRQ3.459-0.189
MRQ3.459TTM3.742-0.283
TTM3.742YOY3.910-0.168
TTM3.7425Y3.032+0.709
5Y3.03210Y2.761+0.272
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Amphastar P.

4.8.1. Institutions holding Amphastar P

Institutions are holding 74.49% of the shares of Amphastar P.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc12.28480.00545942524-136518-2.2457
2024-06-30Vanguard Group Inc5.52550.00212672862-61178-2.2376
2024-09-30TD Asset Management Inc4.41370.0905213503844346926.2164
2024-06-30Federated Hermes Inc4.02040.18441944800-132301-6.3695
2024-06-30Neuberger Berman Group LLC3.35440.05331622609-37208-2.2417
2024-06-30State Street Corp3.1620.00271529536152871.0095
2024-06-30Fuller & Thaler Asset Management Inc2.63130.2181272818-1360-0.1067
2024-06-30Morgan Stanley - Brokerage Accounts2.52260.001912202741021969.1403
2024-06-30TD Global Investment Solutions – TD Epoch2.23030.1971107885228039035.1163
2024-06-30Dimensional Fund Advisors, Inc.2.21250.01121070275-113555-9.5922
2024-06-30Geode Capital Management, LLC1.87370.0032906348403164.6553
2024-06-30American Century Companies Inc1.53060.018174040812176419.6824
2024-06-30Millennium Management LLC1.52720.013773874833865384.6431
2024-06-30T. Rowe Price Associates, Inc.1.20710.0028583906-638-0.1091
2024-06-30Northern Trust Corp1.16620.003856412333410.5958
2024-09-30BTIM Corp1.11560.18225396395396390
2024-06-30Renaissance Technologies Corp1.11160.0365537700-61400-10.2487
2024-06-30BOONE CAPITAL MANAGEMENT LLC1.02355.1651495089-111599-18.3948
2024-06-30Bessemer Group Inc0.96380.03294662287028717.7519
2024-06-30Amvescap Plc.0.93220.00384509304789011.8822
Total 54.8096.228726512707+1347475+5.1%

4.9.2. Funds holding Amphastar P

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31iShares Core S&P Small-Cap ETF5.0020.1449241962823760.0983
2024-09-30Federated Hermes Kaufmann Small Cap A2.70811.5942131000000
2024-09-30Federated Hermes Kaufmann Small Cap Grow2.70811.5942131000000
2024-08-31FullerThaler Behavioral Small-Cap Equity2.48110.5232120019200
2024-06-30FullerThaler Behavioral Sm-Cp Eq R62.48110.523120019200
2024-09-30Vanguard Total Stock Mkt Idx Inv2.3650.0032114403012380.1083
2024-09-30Neuberger Berman Genesis Inv2.20310.48291065715-5331-0.4977
2024-10-31iShares Russell 2000 ETF2.04410.0737988775-2226-0.2246
2024-06-30TD U.S. Capital Reinvestment I1.52150.6013735997-33997-4.4152
2024-09-30Federated Hermes Kaufmann Growth1.27140.585161500000
2024-09-30Federated Hermes Kaufmann R1.27140.584961500000
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr1.16730.0252564655-23152-3.9387
2024-09-30T. Rowe Price Integrated US SmCapGrEq0.87870.237425055-10902-2.5007
2024-09-30T. Rowe Price Integrated US Sm Gr Eq0.87870.237425055-10902-2.5007
2024-08-31Fidelity Small Cap Index0.81260.0702393062-9945-2.4677
2024-10-31Avantis US Small Cap Value ETF0.79870.139938635200
2024-10-31iShares S&P Small-Cap 600 Growth ETF0.76240.296536879200
2024-09-30DFA US Micro Cap I0.74070.227235827500
2024-07-31Old Westbury Small & Mid Cap Strategies0.70470.18343408755774020.3931
2024-10-31iShares Russell 2000 Growth ETF0.70470.14534086100
Total 33.50548.27216207511-35101-0.2%

5.3. Insider Transactions

Insiders are holding 22.469% of the shares of Amphastar P.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-12Rong ZhouSELL689348.88
2024-11-12Richard K PrinsSELL500048.8
2024-11-06William J PetersSELL742652.05
2024-11-06Yakob LiawatidewiSELL521452.05
2024-09-05Floyd F PetersenSELL300046.47
2024-08-26Rong ZhouSELL400048.35
2024-08-12Richard K PrinsSELL1710143.07
2024-07-31William J PetersSELL1028244.23
2024-06-27William J PetersSELL359640.93
2024-06-10Floyd F PetersenSELL300041.4
2024-06-03Floyd F PetersenSELL50042.65
2024-05-01Floyd F PetersenSELL50041.67
2024-04-01Floyd F PetersenSELL50043.43
2024-03-05Michael A ZasloffSELL1250047.18
2024-03-01Floyd F PetersenSELL50045.69
2024-02-01Floyd F PetersenSELL50053.1
2024-01-10Mary Z LuoSELL13138654.59
2024-01-08Mary Z LuoSELL13364458.93
2024-01-02Floyd F PetersenSELL50061.37
2023-12-04Rong ZhouSELL351459.58
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Interest Expense  13,702-4,2469,456-8458,611-28,609-15,307-6,698



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,545,178
Total Liabilities817,500
Total Stockholder Equity727,678
 As reported
Total Liabilities 817,500
Total Stockholder Equity+ 727,678
Total Assets = 1,545,178

Assets

Total Assets1,545,178
Total Current Assets545,949
Long-term Assets999,229
Total Current Assets
Cash And Cash Equivalents 192,116
Short-term Investments 58,375
Net Receivables 139,635
Inventory 130,316
Other Current Assets 25,507
Total Current Assets  (as reported)545,949
Total Current Assets  (calculated)545,949
+/-0
Long-term Assets
Property Plant Equipment 327,518
Long-term Assets Other 23,663
Long-term Assets  (as reported)999,229
Long-term Assets  (calculated)351,181
+/- 648,048

Liabilities & Shareholders' Equity

Total Current Liabilities159,010
Long-term Liabilities658,490
Total Stockholder Equity727,678
Total Current Liabilities
Short-term Debt 4,461
Other Current Liabilities 149,200
Total Current Liabilities  (as reported)159,010
Total Current Liabilities  (calculated)153,661
+/- 5,349
Long-term Liabilities
Long-term Liabilities  (as reported)658,490
Long-term Liabilities  (calculated)0
+/- 658,490
Total Stockholder Equity
Common Stock6
Retained Earnings 530,823
Accumulated Other Comprehensive Income -8,821
Other Stockholders Equity 205,670
Total Stockholder Equity (as reported)727,678
Total Stockholder Equity (calculated)727,678
+/-0
Other
Cash and Short Term Investments 250,491
Common Stock Shares Outstanding 51,862
Liabilities and Stockholders Equity 1,545,178
Net Debt 437,732
Net Working Capital 386,939
Short Long Term Debt Total 629,848



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
> Total Assets 
0
0
0
317,477
0
0
0
338,748
345,109
397,268
401,133
389,370
396,502
398,929
395,027
390,136
395,006
408,586
428,837
427,738
435,612
443,997
437,766
454,665
449,782
451,646
480,642
513,563
544,718
601,301
585,636
586,971
572,831
600,058
613,718
631,236
645,738
665,745
651,677
671,529
716,238
723,719
726,695
741,987
773,656
1,378,266
1,544,633
1,512,912
1,574,317
1,491,522
1,545,178
1,545,1781,491,5221,574,3171,512,9121,544,6331,378,266773,656741,987726,695723,719716,238671,529651,677665,745645,738631,236613,718600,058572,831586,971585,636601,301544,718513,563480,642451,646449,782454,665437,766443,997435,612427,738428,837408,586395,006390,136395,027398,929396,502389,370401,133397,268345,109338,748000317,477000
   > Total Current Assets 
0
0
0
0
0
0
0
172,971
177,290
214,227
215,180
197,996
202,597
203,898
199,059
175,934
173,442
181,313
190,186
184,096
191,417
193,579
176,492
187,778
174,046
169,946
194,804
220,342
230,143
284,134
268,903
255,241
246,724
266,821
276,541
279,682
300,164
310,973
303,671
318,119
364,415
377,145
384,222
378,319
407,670
384,554
543,005
489,600
555,078
482,645
545,949
545,949482,645555,078489,600543,005384,554407,670378,319384,222377,145364,415318,119303,671310,973300,164279,682276,541266,821246,724255,241268,903284,134230,143220,342194,804169,946174,046187,778176,492193,579191,417184,096190,186181,313173,442175,934199,059203,898202,597197,996215,180214,227177,290172,9710000000
       Cash And Cash Equivalents 
0
0
0
50,213
0
0
0
53,587
52,135
64,081
72,881
67,828
68,588
74,463
70,681
66,074
63,332
66,660
66,598
72,354
76,766
82,544
66,920
65,594
54,547
48,070
68,734
86,337
79,096
120,373
85,611
73,685
54,845
87,388
87,910
92,642
101,601
105,432
106,610
126,353
172,627
166,157
157,244
156,098
176,615
148,595
266,778
144,531
201,383
189,854
192,116
192,116189,854201,383144,531266,778148,595176,615156,098157,244166,157172,627126,353106,610105,432101,60192,64287,91087,38854,84573,68585,611120,37379,09686,33768,73448,07054,54765,59466,92082,54476,76672,35466,59866,66063,33266,07470,68174,46368,58867,82872,88164,08152,13553,58700050,213000
       Short-term Investments 
0
0
0
1,888
0
0
0
1,325
1,325
1,495
1,495
1,495
1,495
1,285
1,285
1,285
1,285
1,390
856
527
746
727
2,522
2,635
2,826
2,818
2,829
2,831
2,834
2,836
12,666
11,675
12,203
11,101
10,873
12,977
13,531
11,745
8,021
10,320
14,383
17,234
26,843
19,664
16,277
14,541
33,098
114,710
90,607
30,356
58,375
58,37530,35690,607114,71033,09814,54116,27719,66426,84317,23414,38310,3208,02111,74513,53112,97710,87311,10112,20311,67512,6662,8362,8342,8312,8292,8182,8262,6352,5227277465278561,3901,2851,2851,2851,2851,4951,4951,4951,4951,3251,3250001,888000
       Net Receivables 
0
0
0
0
0
0
0
27,014
22,455
22,839
31,743
23,125
23,986
25,536
31,295
33,471
23,491
23,184
26,709
26,799
26,102
24,509
24,595
42,032
44,077
48,821
47,002
52,212
56,522
49,049
46,145
45,687
58,598
50,544
53,837
66,390
78,738
68,611
78,610
78,930
73,389
86,688
88,464
88,975
101,369
106,044
120,496
114,943
138,114
131,412
139,635
139,635131,412138,114114,943120,496106,044101,36988,97588,46486,68873,38978,93078,61068,61178,73866,39053,83750,54458,59845,68746,14549,04956,52252,21247,00248,82144,07742,03224,59524,50926,10226,79926,70923,18423,49133,47131,29525,53623,98623,12531,74322,83922,45527,0140000000
       Other Current Assets 
0
0
0
25,802
0
0
0
5,033
6,232
3,699
4,913
3,683
3,934
3,264
4,200
4,439
3,092
1,752
3,983
3,272
8,147
7,187
8,660
9,753
5,661
4,404
6,670
5,485
8,956
8,489
10,472
9,538
9,023
8,997
10,986
6,777
6,749
5,895
7,755
7,274
8,869
5,898
8,421
7,563
7,327
5,872
6,196
21,075
9,480
18,992
25,507
25,50718,9929,48021,0756,1965,8727,3277,5638,4215,8988,8697,2747,7555,8956,7496,77710,9868,9979,0239,53810,4728,4898,9565,4856,6704,4045,6619,7538,6607,1878,1473,2723,9831,7523,0924,4394,2003,2643,9343,6834,9133,6996,2325,03300025,802000
   > Long-term Assets 
0
0
0
0
0
0
0
165,777
167,819
183,041
185,953
191,374
193,905
195,031
195,968
214,202
221,564
227,273
238,651
243,642
244,195
250,418
261,274
266,887
275,736
281,700
285,838
293,221
314,575
317,167
316,733
331,730
326,107
333,237
337,177
351,554
345,574
354,772
348,006
353,410
351,823
346,574
342,473
363,668
365,986
993,712
1,001,628
1,023,312
1,019,239
1,008,877
999,229
999,2291,008,8771,019,2391,023,3121,001,628993,712365,986363,668342,473346,574351,823353,410348,006354,772345,574351,554337,177333,237326,107331,730316,733317,167314,575293,221285,838281,700275,736266,887261,274250,418244,195243,642238,651227,273221,564214,202195,968195,031193,905191,374185,953183,041167,819165,7770000000
       Property Plant Equipment 
0
0
0
107,366
0
0
0
116,619
118,565
133,991
134,112
138,289
138,276
139,251
141,181
142,161
144,684
148,647
151,952
152,944
157,389
161,720
173,046
185,339
191,915
198,241
202,526
210,418
229,410
241,188
242,517
253,548
250,208
256,096
266,830
280,709
273,139
280,299
271,015
271,491
271,369
264,727
259,798
264,573
269,986
305,510
314,112
315,643
320,391
320,572
327,518
327,518320,572320,391315,643314,112305,510269,986264,573259,798264,727271,369271,491271,015280,299273,139280,709266,830256,096250,208253,548242,517241,188229,410210,418202,526198,241191,915185,339173,046161,720157,389152,944151,952148,647144,684142,161141,181139,251138,276138,289134,112133,991118,565116,619000107,366000
       Goodwill 
0
0
0
280
0
0
0
280
280
280
4,649
4,467
3,708
3,785
3,832
3,726
4,321
4,159
4,210
3,976
4,031
4,271
4,401
4,461
4,583
4,361
3,997
3,951
3,895
3,930
3,786
3,634
3,571
3,633
3,773
3,940
3,793
3,840
3,386
3,313
3,256
3,054
2,886
3,126
3,175
3,165
3,092
3,216
3,152
3,129
0
03,1293,1523,2163,0923,1653,1753,1262,8863,0543,2563,3133,3863,8403,7933,9403,7733,6333,5713,6343,7863,9303,8953,9513,9974,3614,5834,4614,4014,2714,0313,9764,2104,1594,3213,7263,8323,7853,7084,4674,649280280280000280000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,193
3,985
3,318
3,065
2,690
2,414
1,758
1,462
1,998
15,212
15,163
9,944
0
09,94415,16315,2121,9981,4621,7582,4142,6903,0653,3183,9854,19300000000000000000000000000000000000000
       Intangible Assets 
0
0
0
42,354
0
0
0
39,883
39,410
39,050
38,572
38,098
37,618
37,126
36,653
36,175
39,703
39,139
47,522
46,331
41,962
41,598
41,330
40,679
40,267
39,089
38,730
38,316
38,360
37,788
37,353
37,519
36,901
36,638
36,604
36,675
36,450
36,209
35,806
35,557
35,180
34,646
34,151
34,172
34,004
622,438
616,259
610,079
603,912
597,720
0
0597,720603,912610,079616,259622,43834,00434,17234,15134,64635,18035,55735,80636,20936,45036,67536,60436,63836,90137,51937,35337,78838,36038,31638,73039,08940,26740,67941,33041,59841,96246,33147,52239,13939,70336,17536,65337,12637,61838,09838,57239,05039,41039,88300042,354000
       Other Assets 
0
0
0
44,421
0
0
0
49,158
49,254
49,050
51,841
53,085
55,629
55,780
54,787
72,041
76,880
78,626
86,699
90,698
86,806
88,698
88,228
81,548
38,971
40,009
40,585
40,536
42,910
34,261
33,077
37,029
35,427
36,870
50,919
50,884
32,192
34,424
33,606
39,064
38,700
41,082
42,948
59,383
0
61,137
0
0
0
0
0
0000061,137059,38342,94841,08238,70039,06433,60634,42432,19250,88450,91936,87035,42737,02933,07734,26142,91040,53640,58540,00938,97181,54888,22888,69886,80690,69886,69978,62676,88072,04154,78755,78055,62953,08551,84149,05049,25449,15800044,421000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
6,118
6,118
6,932
9,856
9,907
9,938
27,444
27,444
27,444
27,423
31,001
31,874
31,874
31,874
27,745
28,257
28,257
29,458
30,618
30,618
20,746
20,746
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000020,74620,74630,61830,61829,45828,25728,25727,74531,87431,87431,87431,00127,42327,44427,44427,4449,9389,9079,8566,9326,1186,118000000000
> Total Liabilities 
0
0
0
84,038
0
0
0
87,203
93,567
109,527
118,013
107,510
117,221
113,664
111,241
94,626
98,421
101,122
100,384
98,483
110,051
110,683
107,111
117,336
122,678
131,120
139,372
149,204
164,452
169,013
151,983
159,443
149,458
157,621
162,756
182,513
194,778
198,522
221,501
226,007
236,713
224,412
221,530
213,329
225,079
789,031
949,493
873,491
901,961
778,176
817,500
817,500778,176901,961873,491949,493789,031225,079213,329221,530224,412236,713226,007221,501198,522194,778182,513162,756157,621149,458159,443151,983169,013164,452149,204139,372131,120122,678117,336107,111110,683110,05198,483100,384101,12298,42194,626111,241113,664117,221107,510118,013109,52793,56787,20300084,038000
   > Total Current Liabilities 
0
0
0
60,075
0
0
0
65,402
72,813
56,282
63,082
62,595
72,090
69,404
70,653
59,955
64,921
65,667
60,837
60,617
72,861
63,701
57,397
67,192
72,542
87,590
96,621
106,834
111,959
100,999
86,596
90,009
83,371
93,286
96,717
112,201
127,096
124,549
97,989
103,810
114,364
103,634
102,190
94,862
105,635
251,285
257,963
225,407
255,169
136,971
159,010
159,010136,971255,169225,407257,963251,285105,63594,862102,190103,634114,364103,81097,989124,549127,096112,20196,71793,28683,37190,00986,596100,999111,959106,83496,62187,59072,54267,19257,39763,70172,86160,61760,83765,66764,92159,95570,65369,40472,09062,59563,08256,28272,81365,40200060,075000
       Short-term Debt 
0
0
0
0
0
0
0
22,104
31,888
10,665
10,078
7,594
12,531
12,632
14,762
10,934
11,177
10,904
8,541
5,366
5,263
6,205
6,212
6,312
6,061
18,891
18,592
18,229
20,147
9,678
10,059
10,916
14,939
15,556
15,806
15,620
15,875
11,314
5,118
5,184
5,438
5,372
4,863
6,049
5,159
16,053
4,152
8,248
4,370
8,241
4,461
4,4618,2414,3708,2484,15216,0535,1596,0494,8635,3725,4385,1845,11811,31415,87515,62015,80615,55614,93910,91610,0599,67820,14718,22918,59218,8916,0616,3126,2126,2055,2635,3668,54110,90411,17710,93414,76212,63212,5317,59410,07810,66531,88822,1040000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
7,594
0
0
0
10,934
0
10,904
8,541
5,366
5,263
46,312
6,212
5,985
6,061
18,891
18,592
17,886
17,587
6,941
6,969
7,741
11,458
12,075
12,167
12,263
12,173
8,077
2,256
2,202
2,159
2,057
1,680
3,046
2,168
12,920
433
436
428
249
0
024942843643312,9202,1683,0461,6802,0572,1592,2022,2568,07712,17312,26312,16712,07511,4587,7416,9696,94117,58717,88618,59218,8916,0615,9856,21246,3125,2635,3668,54110,904010,9340007,59400000000000
       Accounts payable 
0
0
0
17,663
0
0
0
20,380
17,571
17,764
10,013
10,161
18,948
18,447
12,265
13,872
18,619
18,767
13,439
16,196
19,302
14,910
9,590
16,629
58,498
67,092
22,668
87,418
90,795
88,171
75,137
77,051
65,438
75,385
23,170
95,504
22,987
27,752
88,911
89,545
23,843
97,665
95,796
84,242
88,886
217,536
222,719
25,438
36,534
31,775
0
031,77536,53425,438222,719217,53688,88684,24295,79697,66523,84389,54588,91127,75222,98795,50423,17075,38565,43877,05175,13788,17190,79587,41822,66867,09258,49816,6299,59014,91019,30216,19613,43918,76718,61913,87212,26518,44718,94810,16110,01317,76417,57120,38000017,663000
       Other Current Liabilities 
0
0
0
17,328
0
0
0
22,275
22,711
27,210
28,395
30,827
33,725
33,958
42,983
34,506
34,482
34,335
38,027
38,958
48,016
42,163
40,380
44,251
50,850
47,036
55,361
57,282
2,560
59,859
54,493
54,032
51,926
56,022
57,741
72,224
88,234
85,483
71,213
76,412
85,083
597
1,531
4,571
11,590
235,232
252,305
190,112
202,551
95,441
149,200
149,20095,441202,551190,112252,305235,23211,5904,5711,53159785,08376,41271,21385,48388,23472,22457,74156,02251,92654,03254,49359,8592,56057,28255,36147,03650,85044,25140,38042,16348,01638,95838,02734,33534,48234,50642,98333,95833,72530,82728,39527,21022,71122,27500017,328000
   > Long-term Liabilities 
0
0
0
0
0
0
0
21,801
20,754
53,245
54,931
44,915
45,131
44,260
40,588
34,671
33,500
35,455
39,547
37,866
37,190
46,982
49,714
50,144
50,136
43,530
42,751
42,370
52,493
68,014
65,387
69,434
66,087
64,335
66,039
70,312
67,682
73,973
123,512
122,197
122,349
120,778
119,340
118,467
119,444
537,746
691,530
648,084
646,792
641,205
658,490
658,490641,205646,792648,084691,530537,746119,444118,467119,340120,778122,349122,197123,51273,97367,68270,31266,03964,33566,08769,43465,38768,01452,49342,37042,75143,53050,13650,14449,71446,98237,19037,86639,54735,45533,50034,67140,58844,26045,13144,91554,93153,24520,75421,8010000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
42,850
41,271
36,106
35,886
34,798
31,354
30,165
29,092
31,742
34,163
32,356
31,148
40,107
42,232
40,844
39,706
33,695
32,606
31,984
30,973
39,793
38,079
39,394
36,410
34,622
32,903
34,186
32,334
30,460
75,552
74,776
74,348
73,871
74,011
72,839
72,872
488,280
0
0
0
0
0
00000488,28072,87272,83974,01173,87174,34874,77675,55230,46032,33434,18632,90334,62236,41039,39438,07939,79330,97331,98432,60633,69539,70640,84442,23240,10731,14832,35634,16331,74229,09230,16531,35434,79835,88636,10641,27142,850000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
6,118
6,118
6,932
9,856
9,907
9,938
27,444
27,444
27,444
27,423
31,001
31,874
31,874
31,874
27,745
28,257
28,257
29,458
30,618
30,618
20,746
20,746
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000020,74620,74630,61830,61829,45828,25728,25727,74531,87431,87431,87431,00127,42327,44427,44427,4449,9389,9079,8566,9326,1186,118000000000
       Other Liabilities 
0
0
0
4,992
0
0
0
4,578
3,988
3,241
2,934
2,971
3,406
3,624
3,396
4,506
4,408
3,713
3,768
4,055
4,569
5,337
5,896
7,939
10,430
9,835
10,145
10,386
10,346
10,467
10,368
13,725
14,447
15,183
15,602
18,662
18,884
18,958
22,494
22,718
22,512
22,227
20,963
21,934
0
25,059
0
0
0
0
0
0000025,059021,93420,96322,22722,51222,71822,49418,95818,88418,66215,60215,18314,44713,72510,36810,46710,34610,38610,1459,83510,4307,9395,8965,3374,5694,0553,7683,7134,4084,5063,3963,6243,4062,9712,9343,2413,9884,5780004,992000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
9,457
12,869
7,820
7,660
7,499
7,338
1,339
1,179
166
1,784
1,552
1,753
1,961
2,801
1,361
1,425
1,325
1,303
1,031
1,067
1,025
976
867
765
760
823
741
755
765
2,901
534
0
0
0
0
0
0
0
0
0
0
0
000000000005342,9017657557418237607658679761,0251,0671,0311,3031,3251,4251,3612,8011,9611,7531,5521,7841661,1791,3397,3387,4997,6607,82012,8699,457000000000
> Total Stockholder Equity
0
0
0
233,439
0
0
0
251,545
251,542
287,741
283,120
281,860
279,281
285,265
283,786
295,510
296,585
307,464
328,453
329,255
325,561
333,314
330,655
337,329
327,104
320,526
319,416
332,435
334,986
387,845
389,405
381,366
377,514
397,681
405,232
402,306
405,558
421,993
430,176
445,522
479,525
499,307
505,165
528,658
548,577
589,235
595,140
639,421
672,356
713,346
727,678
727,678713,346672,356639,421595,140589,235548,577528,658505,165499,307479,525445,522430,176421,993405,558402,306405,232397,681377,514381,366389,405387,845334,986332,435319,416320,526327,104337,329330,655333,314325,561329,255328,453307,464296,585295,510283,786285,265279,281281,860283,120287,741251,542251,545000233,439000
   Common Stock
0
0
0
4
0
0
0
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
666666666666666555555555555555555555554444440004000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
71,010
65,631
63,110
62,445
55,798
52,790
60,323
62,812
69,707
73,597
70,855
72,620
74,592
74,767
76,235
69,570
66,780
65,618
67,485
68,299
116,086
117,396
116,370
120,319
120,127
124,046
117,773
122,814
130,581
160,577
180,337
204,590
221,936
237,810
271,723
297,755
323,880
0
0
0
0
0
00000323,880297,755271,723237,810221,936204,590180,337160,577130,581122,814117,773124,046120,127120,319116,370117,396116,08668,29967,48565,61866,78069,57076,23574,76774,59272,62070,85573,59769,70762,81260,32352,79055,79862,44563,11065,63171,010000000000
   Accumulated Other Comprehensive Income -8,821-8,826-8,769-8,478-8,411-8,324-8,268-8,624-9,931-8,709-7,245-6,765-6,277-4,931-5,642-3,721-4,478-5,173-5,461-4,687-5,848-4,223-4,126-4,013-3,576-3,166-910-2,100-2,595-3,220-4,230-4,696-2,581-2,690-2,039-2,475-3,760-4,134-4,647-1,654-1,803-268-93,246-90,5750000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
216,995
219,288
220,745
223,313
236,656
240,745
247,829
250,683
258,786
276,543
283,123
285,356
299,105
303,208
313,891
316,665
322,357
330,265
344,434
349,201
355,436
361,705
367,305
371,144
396,841
404,084
410,061
413,926
427,301
412,917
422,423
433,454
443,042
448,741
455,077
456,623
471,110
0
0
0
0
0
00000471,110456,623455,077448,741443,042433,454422,423412,917427,301413,926410,061404,084396,841371,144367,305361,705355,436349,201344,434330,265322,357316,665313,891303,208299,105285,356283,123276,543258,786250,683247,829240,745236,656223,313220,745219,288216,995000000000
   Treasury Stock00000-197,437-197,539-189,524-171,461-156,968-151,280-150,479-137,047-130,964-125,546-121,812-118,425-114,119-108,493-97,627-83,853-79,459-78,393-75,476-72,896-65,450-58,226-50,702-44,730-37,168-28,190-20,032-19,111-18,344-14,876-10,172-5,994-3,060-1,834-34500000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
177,732
179,348
216,995
219,288
220,400
221,479
233,596
234,751
237,657
235,807
240,442
257,432
263,091
257,166
261,937
258,478
263,189
258,439
256,907
257,369
268,958
270,808
275,977
277,852
269,678
262,651
282,722
285,659
288,249
288,380
296,337
275,870
271,944
282,174
286,074
277,280
265,553
259,084
273,673
230,443
238,625
228,674
231,772
205,670
205,670231,772228,674238,625230,443273,673259,084265,553277,280286,074282,174271,944275,870296,337288,380288,249285,659282,722262,651269,678277,852275,977270,808268,958257,369256,907258,439263,189258,478261,937257,166263,091257,432240,442235,807237,657234,751233,596221,479220,400219,288216,995179,348177,7320000000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.